Published in Cardiovascular Business Week, January 10th, 2006
Organizations profiled in this study include: Aderis, Atherogenics, Atrix, Bristol-Myers Squibb, Medical Imaging, Cardiome, CV Therapeutics, Micrologix, GlaxoSmithKline and Fujisawa.
One of the focus areas of the study is "deal making and implementation" which reveals the winning strategies and practices of nine pharmaceutical and biotech companies that have successfully negotiated and implemented...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.